151 related articles for article (PubMed ID: 32399118)
1. Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk.
Yuan C; Liu X; Li R; Yan S; Kong B
Arch Med Sci; 2020; 16(3):682-691. PubMed ID: 32399118
[TBL] [Abstract][Full Text] [Related]
2. Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.
Kamali M; Hamadani S; Neamatzadeh H; Mazaheri M; Zare Shehneh M; Modaress Gilani M; Haghighi F
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1743-1749. PubMed ID: 28749098
[TBL] [Abstract][Full Text] [Related]
3. The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.
Shi S; Qin L; Tian M; Xie M; Li X; Qi C; Yi X
Tumour Biol; 2014 Jun; 35(6):5797-804. PubMed ID: 24599673
[TBL] [Abstract][Full Text] [Related]
4. Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer.
Zhang W; Zhang Z
Oncotarget; 2016 Dec; 7(52):86621-86629. PubMed ID: 27863412
[TBL] [Abstract][Full Text] [Related]
5. XRCC2 Arg188His polymorphism and colorectal cancer risk: a meta-analysis.
Wang Z; Wei Y; An L; Xi C; Wang K; Hong D; Shi Y; Zang A; Su S; Li W
J Int Med Res; 2021 Oct; 49(10):3000605211039473. PubMed ID: 34648414
[TBL] [Abstract][Full Text] [Related]
6. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
7. Association of RAD51 and XRCC2 Gene Polymorphisms with Cervical Cancer Risk in the Bangladeshi Women.
Ivy SC; Shabnaz S; Shahriar M; Jafrin S; Aka TD; Aziz MA; Islam MS
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2099-2107. PubMed ID: 34319032
[TBL] [Abstract][Full Text] [Related]
8. The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies.
Huang X; Gao Y; He J; Cai J; Ta N; Jiang H; Zhu J; Zheng J
J Cancer; 2016; 7(2):144-52. PubMed ID: 26819637
[TBL] [Abstract][Full Text] [Related]
9. Association between XRCC2 Arg188His Polymorphism and Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
Dastgheib SA; Sayad S; Azizi S; Hajizadeh N; Asadian F; Karimi-Zarchi M; Barahman M; Shiri A; Manzourolhojeh M; Aghili K; Neamatzadeh H
Asian Pac J Cancer Prev; 2024 Jan; 25(1):43-55. PubMed ID: 38285766
[TBL] [Abstract][Full Text] [Related]
10. XPG Asp1104His, XRCC2 Rs3218536 A/G and RAD51 135G/C Gene Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis.
Eskandari E; Rezaifar A; Hashemi M
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1805-1813. PubMed ID: 28749109
[TBL] [Abstract][Full Text] [Related]
11. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
[TBL] [Abstract][Full Text] [Related]
12. Impact of XRCC2 Arg188His polymorphism on cancer susceptibility: a meta-analysis.
He Y; Zhang Y; Jin C; Deng X; Wei M; Wu Q; Yang T; Zhou Y; Wang Z
PLoS One; 2014; 9(3):e91202. PubMed ID: 24621646
[TBL] [Abstract][Full Text] [Related]
13. Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects.
Kong B; Lv ZD; Chen L; Shen RW; Jin LY; Yang ZC
Int J Clin Exp Med; 2015; 8(9):15808-14. PubMed ID: 26629080
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variations of RAD51 and XRCC2 Genes Increase the Risk of Colorectal Cancer in Bangladeshi Population.
Hridy AU; Shabnaz S; Asaduzzaman MD; Shahriar M; Bhuiyan MA; Islam MS; Hossen SMM; Emran TB
Asian Pac J Cancer Prev; 2020 May; 21(5):1445-1451. PubMed ID: 32458654
[TBL] [Abstract][Full Text] [Related]
15. ERCC2 Lys751Gln rs13181 and XRCC2 Arg188His rs3218536 Gene Polymorphisms Contribute to Subsceptibility of Colon, Gastric, HCC, Lung And Prostate Cancer.
Balkan E; Bilici M; Gundogdu B; Aksungur N; Kara A; Yasar E; Dogan H; Ozturk G
J BUON; 2020; 25(1):574-581. PubMed ID: 32277685
[TBL] [Abstract][Full Text] [Related]
16. CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.
Xu XM; Ni XB; Yang GL; Luo ZG; Niu YM; Shen M
Mol Clin Oncol; 2016 Jun; 4(6):1078-1084. PubMed ID: 27284448
[TBL] [Abstract][Full Text] [Related]
17.
Wang LN; Wang F; Liu J; Jin YH; Fang C; Ren XQ
Front Physiol; 2017; 8():1081. PubMed ID: 29326607
[No Abstract] [Full Text] [Related]
18. A role for XRCC2 gene polymorphisms in breast cancer risk and survival.
Lin WY; Camp NJ; Cannon-Albright LA; Allen-Brady K; Balasubramanian S; Reed MW; Hopper JL; Apicella C; Giles GG; Southey MC; Milne RL; Arias-Pérez JI; Menéndez-Rodríguez P; Benítez J; Grundmann M; Dubrowinskaja N; Park-Simon TW; Dörk T; Garcia-Closas M; Figueroa J; Sherman M; Lissowska J; Easton DF; Dunning AM; Rajaraman P; Sigurdson AJ; Doody MM; Linet MS; Pharoah PD; Schmidt MK; Cox A
J Med Genet; 2011 Jul; 48(7):477-84. PubMed ID: 21632523
[TBL] [Abstract][Full Text] [Related]
19. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
20. Association between IL-17A G197A polymorphism and gastric cancer risk: an updated meta-analysis based on 6,624 cases and 7,631 controls.
Hu L; Kong F; Pan Y
Onco Targets Ther; 2018; 11():703-710. PubMed ID: 29440917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
